Posts tagged as: candlestick charts back to homepage

Teryl Resources Corp Stock Chart Analysis Video Teryl Resources Corp Stock Chart Analysis Video(0)

The Teryl Resources Corp. (TSX-Venture:TRC) stock chart hit a bottom late last year at a nickel and has been steadily making higher lows since.  Support is solid at 5.5 and 6 cents with resistance not coming into play until 8.5 and 10 cents.  The indicators are Read More

Premier Alliance Group Stock Chart Analysis Video Premier Alliance Group Stock Chart Analysis Video(0)

The Premier Alliance Group, Inc. (OTCBB:PIMO) stock chart has moved off a bottom of 40 cents that was struck early in 2012 and climbed as high as $1.25 last month.  The stock price has settled back down to close yesterday and 76 cents, making a higher low as the MACD and RSI continue on upward paths signaling strength of trend and momentum.  Primary resistance doesn’t enter the chart until another climb to $1.00 with a first level of support at Read More

NavStar Technologies Stock Chart Analysis - Double Bottom Pattern(0)

The NavStar Technologies, Inc. (Pink Sheets:NVSR) chart has formed a classic double bottom pattern with support holding at a nickel. The stock climbed yesterday on light volume, which could be a prelude to a larger move to come. Resistance is mixed with top-end resistance for the pattern at 25 cents. The nickel support must hold. Read More

Auri Inc Stock Chart Analysis Video(0)

Shares of Auri, Inc. (OTCBB:AURI) have consolidated mildly since a climb from 4 cents to 9 cents. The indicators are holding bullish positions which are signaling that the chart may be ready for another run at resistance and the 50 dma at $0.09 as support is being established at 6 cents. Read More

BioLargo Stock Chart Analysis Video(0)

A thin-floater, the BioLargo chart is climbing again as it has historically done off a bottom support at 20 cents. Technical traders will be watching for a 20 percent climb to take out resistance at 40 cents, which could free a path to the next resistance at 60 cents. Read More

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.